Business Development Representative - Digital Pathology

Epredia•Boston, MA

2d•$132,750 - $150,000•Remote

About The Position

Digital Pathology is one of Epredia's most strategic platforms. As a Business Development Representative, this role is key in driving the growth of Digital Pathology in the Northeast US region. You'll build and execute a winning sales strategy, manage a robust territory pipeline, and manage various customer accounts in clinical and lab spaces. This significant role will work collaboratively with internal and external stakeholders to drive sales and contribute to Epredia's next phase of growth! This is a remote field sales position that supports the Northeast US region, ideally located in the Greater Boston area.

Requirements

Bachelor’s degree is required.
5+ years of experience in capital equipment sales into either a clinical or research environments.
Confirmed technical writing skills, ability to work with minimal direction in a laboratory/hospital environment and in the field.
Up to 75% travel is required

Nice To Haves

2+ years of experience in digital pathology industry is preferred.

Responsibilities

Achieve monthly, quarterly, and annual product sales goals set for the territory.
Develop and implement a successful sales strategy for rapid revenue growth and market share expansion in the territory.
Work collaboratively with sales and service counterparts to achieve Epredia performance targets.
Interpret and understand customer user requirements, and how they relate to product functionality and performance.
Manage region and DP product portfolio to achieve quarterly goals.
Coordinate and perform product demos, installs, and customer training with the Field Applications team.
Collaborate on commercialization efforts with Marketing for new products and software launches.
Own the sales process and closing from Account Executive and other lead generating salespeople.
Report, track, and manage all opportunities and customer data in SFDC.
Review available technical literature to maintain an awareness of current IHC and digital pathology opportunities and regulatory rules—including appropriate market positioning.